Raghu Rao insider trades: Sonnet BioTherapeutics Holdings (SONN) SEC Form 4 filings
Companies
Where Raghu reports to the SEC
About Raghu Rao's insider trades
Raghu Rao is Chief Executive Officer at Sonnet BioTherapeutics Holdings (SONN). Raghu has not reported an open-market purchase or sale.
Their filings also include grants and awards (6 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SONN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.